For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260415:nRSO4588Aa&default-theme=true
RNS Number : 4588A Light Science Tech. Holdings PLC 15 April 2026
Light Science Technologies Holdings plc
("LSTH", "Light Science", the "Company" or the "Group")
Completion of Acquisitions
Light Science Technologies Holdings plc (AIM: LST), the innovative technology
and manufacturing business providing real-world solutions targeting issues
including global food security and fire safety, is pleased to confirm that,
further to its announcement on 11 March 2026, the acquisitions of RLUK
Injection Ltd (including its wholly owned subsidiary Injectaclad Ltd), the
remaining 10% minority interest in UK Circuits and Electronics Solutions
Limited, and the related property have now completed.
For additional information please contact:
Light Science Technologies Holdings plc www.lightsciencetechnologiesholdings.com
(https://protect.checkpoint.com/v2/r02/___http:/www.lightsciencetechnologiesholdings.com___.YXAxZTpzaG9yZWNhcDpjOm86NjFkNDQ2ZGJkM2Y4MGQxOTJlOTNlMmQ2MDAyNmZiMTE6NzphMjJlOjQyNjVlZTE5YzU5MzIxMDNlNzE1OGUwYWEwZWVhMDg4NTZlNTViMGY3YTM2OGQ4MzMxZjU0ZjNlN2MyZjZmYzA6cDpGOk4)
Simon Deacon, Chief Executive Officer
via Walbrook PR
Jim Snooks, Chief Financial Officer
Andrew Hempsall, Chief Operating Officer
Shore Capital (Nominated Adviser and Broker) +44 (0)20 7408 4050
Stephane Auton / George Payne
Walbrook PR Ltd (Media & Investor Relations) Tel: +44 (0)20 7933 8780 or lst@walbrookpr.com (mailto:lst@walbrookpr.com)
Nick Rome / Marcus Ulker
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACQBUGDSLXBDGLS
Copyright 2019 Regulatory News Service, all rights reserved
Recent news on Light Science Technologies Holdings